LabCorp Named Laboratory Service Provider of the Pro Football Legends
December 17 2014 - 08:45AM
Business Wire
Pro Football Legends, the commercial marketing arm of the
National Football League Alumni, Inc. (NFL Alumni) and Laboratory
Corporation of America® Holdings (LabCorp®) (NYSE: LH) are pleased
to announce that they have entered into an agreement for LabCorp to
be a sponsor of Pro Football Legends. Under this agreement, LabCorp
will offer to provide diagnostic testing services for NFL Alumni
members and their families.
“This partnership tackles one of our highest priorities, which
is helping our members manage their health needs,” said Joseph
Pisarcik, President and CEO of the NFL Alumni. “Having been a
LabCorp patient for many years, I couldn’t be more excited about
forging this relationship for the benefit of our NFL Alumni members
and their families.”
LabCorp will provide access to a comprehensive range of high
quality diagnostic testing services, including blood work, to NFL
Alumni members and their dependents. This arrangement for
laboratory services follows earlier NFL Alumni initiatives to make
other healthcare services available to its members, such as
prostate and diabetes screening and discounted hearing aid
technology. Although many former NFL players are healthy and
financially secure, others face challenges in their post-football
lives. The NFL Alumni’s mission is to serve, assist and inform
former players and their families through medical, financial and
social programs intended to help members lead healthy, productive
lives.
The LabCorp program, which begins this month with the NFL
Alumni’s Philadelphia and New York/New Jersey Chapters, will roll
out nationally to all NFL Alumni chapters in the next 60 days.
Laboratory services will be made available to NFL Alumni members
and their dependents who don’t have health insurance.
“LabCorp is excited about this partnership, and we look forward
to working with all NFL Alumni chapters across the U.S.,” said
James T. Boyle, Jr., LabCorp’s Chief Operating Officer. “LabCorp
and its employees have always been strong supporters of
community-based efforts to expand access to healthcare, in addition
to giving time and resources to support similar causes. We are
pleased to implement this program with the NFL Alumni and its
members.”
About the Pro Football Legends
Pro Football Legends is the commercial marketing name and logo
of the NFL Alumni Association, a nationwide group of former
National Football League players, coaches and other employees whose
mission is to serve, assist and inform former players and their
families. The association offers a variety of medical, financial
and social programs to help members lead healthy, productive and
connected lives, as well as community initiatives under its “Caring
for Kids” programs. For more information please visit
www.nflalumni.org.
About LabCorp®
Laboratory Corporation of America® Holdings, an S&P 500
company, is a pioneer in commercializing new diagnostic
technologies and the first in its industry to embrace genomic
testing. With annual revenues of $5.8 billion in 2013, over 34,000
employees worldwide, and more than 220,000 clients, LabCorp offers
more than 4,000 tests ranging from routine blood analyses to
reproductive genetics to companion diagnostics. LabCorp furthers
its scientific expertise and innovative clinical testing technology
through its LabCorp Specialty Testing Group: The Center for
Molecular Biology and Pathology, National Genetics Institute,
ViroMed Laboratories, Inc, The Center for Esoteric Testing,
Litholink Corporation, Integrated Genetics, Integrated Oncology,
Dianon Pathology, Monogram Biosciences, Inc, Colorado Coagulation,
Cellmark Forensics, MedTox, and Endocrine Sciences. LabCorp
conducts clinical trials testing through its LabCorp Clinical
Trials division. LabCorp clients include physicians, government
agencies, managed care organizations, hospitals, clinical labs, and
pharmaceutical companies. To learn more about our organization,
visit our website at: www.labcorp.com.
This press release contains forward-looking statements including
with respect to estimated 2014 guidance and the impact of various
factors on operating results. Each of the forward-looking
statements is subject to change based on various important factors,
including without limitation, competitive actions in the
marketplace and adverse actions of governmental and other
third-party payers. Actual results could differ materially from
those suggested by these forward-looking statements. Further
information on potential factors that could affect LabCorp’s
operating and financial results is included in the Company’s Form
10-K for the year ended December 31, 2013, including under the
heading risk factors, and in the Company’s other filings with the
SEC. The information in this press release should be read in
conjunction with a review of the Company’s filings with the SEC
including the information in the section of the Company’s Form 10-K
for the year ended December 31, 2013 and subsequent Forms 10-Q
under the heading MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20141217005069/en/
LabCorp Investor/Media Contact:Stephen Anderson,
336-436-5076Media@labcorp.comCompany Information:
www.labcorp.comorNFLA Contact:Jamie DeVivo,
908-546-7447jamie@zitopartners.com
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From Feb 2024 to Mar 2024
Laboratory Corporation o... (NYSE:LH)
Historical Stock Chart
From Mar 2023 to Mar 2024